Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment

File(s)

Manuscript Cenicriviroc CSF exposure BJCP letter editor 21 jan clean.docx (42.26 KB)

Accepted version

Show more

Author(s)

Alagaratnam, Jasmini

Dilly-Penchala, Sujan

Challenger, Elizabeth

Else, Laura

Legg, Ken

more

Type

Journal Article

Date Issued

2019-05-01

Date Acceptance

2019-01-20

Citation

British Journal of Clinical Pharmacology, 2019, 85 (5), pp.1039-1040

URI

http://hdl.handle.net/10044/1/73286

URL

https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13878

DOI

https://www.dx.doi.org/10.1111/bcp.13878

ISSN

0306-5251

Publisher

Wiley

Start Page

1039

End Page

1040

Journal / Book Title

British Journal of Clinical Pharmacology

Volume

85

Issue

5

Copyright Statement

© 2019 The British Pharmacological Society. This is the accepted version of the following article: Alagaratnam, J, Dilly‐Penchala, S, Challenger, E, et al. Cerebrospinal fluid exposure of cenicriviroc in HIV‐positive individuals with cognitive impairment. Br J Clin Pharmacol. 2019; 85: 1039– 1040, which has been published in final form at https://doi.org/10.1111/bcp.13878

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000465241100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Publication Status

Published

Date Publish Online

2019-03-04